Faculty profile

Rayjean Hung

Back to faculty

ProfessorEndocrinology and MetabolismUniversity of Toronto

Rayjean Hung

Professor

Endocrinology and Metabolism

Dalla Lana School of Public Health

University of Toronto

Toronto, Ontario, Canada

Canada Research Chair in Integrative Molecular Epidemiology

Scholar ORCID

Supervision signals

Professors usually supervise graduate students in their department's programs.
3 publications in the last five years, latest in 2026.
Principal investigator on 9 research grants (9 CIHR), most recently in 2026.
Supervised 6 trainees who won CIHR awards, most recently in 2026.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Education

Ph.D. Epidemiology

Profiles and links

University Profile Personal Website Google Scholar iDORCID

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Cardiometabolic Risk Risk Prediction Crc Genomics Diabetes Insulin Resistance Lifestyle Intervention Lipidomics

Latest papers

Seasonal moderators of maternal CRP levels during pregnancy.
Brain, behavior, & immunity - health · 2026
Prospective harmonisation of four international randomised controlled trials in Canada, China, India and South Africa: the Healthy Life Trajectories Initiative
BMJ Open · 2025
The effect of body mass index at diagnosis on survival of patients with squamous cell head and neck carcinoma.
American journal of cancer research · 2024

All 10 publications

Latest funding

Pre-diagnostic serological evidence of infection and lung cancer risk: a multi-pathogen investigation in the United Kingdom Biobank
CIHR · 2026 · Supervisor
$9,000
Intervening across the first 2000 Days of Life to Transform a Lifetime
CIHR · 2026 · Principal investigator
$930,874
Identifying Patients in whom Remission of Type 2 Diabetes can be Achieved
CIHR · 2025 · Principal investigator
$100,000

All 20 grants and awards

10 publications.

Seasonal moderators of maternal CRP levels during pregnancy.

Zhang CXW, Levinsky J, Korczak D, McGowan P, Wade M, Knight JA, Hung R, Bertoni K, Murphy K, Lye S, Matthews SG, Levitan RD

Brain, behavior, & immunity - health2026

DOI: 10.1016/j.bbih.2026.101326 PMID: 42633115

Prospective harmonisation of four international randomised controlled trials in Canada, China, India and South Africa: the Healthy Life Trajectories Initiative

Bergeron J, Nechba A, Tiali SEB, Atkinson S, Birken C, Draper C, Krishnaveni GV, Fraser W, Dennis CL, Abdelouahab N

BMJ Open20251 citations

DOI: 10.1136/bmjopen-2024-086233

The effect of body mass index at diagnosis on survival of patients with squamous cell head and neck carcinoma.

Pastorino R, Pires Marafon D, Lentini N, Hoxhaj I, Grossi A, Giraldi L, Rondinò A, Cadoni G, Polesel J, Serraino D, La Vecchia C, Garavello W, Canova C, Richiardi L, Lissowska J, Pandics T, Dudding T, Ness A, Thomas S, Pring M, Kelsey K, McClean M, Bradshaw P, Zhang ZF, Morgenstern H, Rozek L, Wolf G, Olshan A, Liu G, Hung R, Vilensky M, Brasilino de Carvalho M, Mendonza López RV, Wunsch-Filho V, Boffetta P, Hashibe M, Amy Lee YC, Boccia S

American journal of cancer research2024

DOI: 10.62347/uuxk7608 PMID: 39659941

A reply to "Lung cancer outcomes: Are BMI and race clinically relevant?".

Liu G, Brenner H, Chen C, Christiani D, Field JK, Hung R, Jie Z, Le Marchand L, Ryan B, Schabath MB, Schwartz AG, Shete S, Shiraishi K, Tardon A, Teare MD, Yang P, Zhang ZF, Xu W

Lung cancer (Amsterdam, Netherlands)2021

DOI: 10.1016/j.lungcan.2021.02.019 PMID: 33726925

Using Precision Medicine with a Neurodevelopmental Perspective to Study Inflammation and Depression.

Levitan RD, Zhang CXW, Knight JA, Hung R, Lye J, Murphy K, Atkinson L, Bocking A, Lye S, Matthews SG

Current psychiatry reports2020

DOI: 10.1007/s11920-020-01206-8 PMID: 33289044

Appraising the causal relevance of DNA methylation for risk of lung cancer.

Battram T, Richmond RC, Baglietto L, Haycock PC, Perduca V, Bojesen SE, Gaunt TR, Hemani G, Guida F, Carreras-Torres R, Hung R, Amos CI, Freeman JR, Sandanger TM, Nøst TH, Nordestgaard BG, Teschendorff AE, Polidoro S, Vineis P, Severi G, Hodge AM, Giles GG, Grankvist K, Johansson MB, Johansson M, Davey Smith G, Relton CL

International journal of epidemiology2019

DOI: 10.1093/ije/dyz190 PMID: 31549173

Heritable Germline Variation and Lung Cancer Susceptibility: One Size Does not Fit All.

Herman M, Warkentin MT, Shepshelovich D, Latifovic L, Hung R, Liu G

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2018

DOI: 10.1016/j.jtho.2018.02.018 PMID: 29703536

BRM Promoter Polymorphisms and Survival of Advanced Non-Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial.

Liu G, Cuffe S, Liang S, Azad AK, Cheng L, Brhane Y, Qiu X, Cescon DW, Bruce J, Chen Z, Cheng D, Patel D, Tse BC, Laurie SA, Goss G, Leighl NB, Hung R, Bradbury PA, Seymour L, Shepherd FA, Tsao MS, Chen BE, Xu W, Reisman DN

Clinical cancer research : an official journal of the American Association for Cancer Research2017

DOI: 10.1158/1078-0432.ccr-16-1640 PMID: 27827316

Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk.

Patel YM, Park SL, Han Y, Wilkens LR, Bickeböller H, Rosenberger A, Caporaso N, Landi MT, Brüske I, Risch A, Wei Y, Christiani DC, Brennan P, Houlston R, McKay J, McLaughlin J, Hung R, Murphy S, Stram DO, Amos C, Le Marchand L

Cancer research2016

DOI: 10.1158/0008-5472.can-16-0446 PMID: 27488534

BRM polymorphisms, pancreatic cancer risk and survival

Segedi M, Anderson LN, Espin‐Garcia O, Borgida A, Bianco T, Cheng D, Chen Z, Patel D, Brown MC, Xu W

International Journal of Cancer201616 citations

DOI: 10.1002/ijc.30369

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Rayjean Hung

Research

Latest papers

Latest funding

Seasonal moderators of maternal CRP levels during pregnancy.

Prospective harmonisation of four international randomised controlled trials in Canada, China, India and South Africa: the Healthy Life Trajectories Initiative

The effect of body mass index at diagnosis on survival of patients with squamous cell head and neck carcinoma.

A reply to "Lung cancer outcomes: Are BMI and race clinically relevant?".

Using Precision Medicine with a Neurodevelopmental Perspective to Study Inflammation and Depression.

Appraising the causal relevance of DNA methylation for risk of lung cancer.

Heritable Germline Variation and Lung Cancer Susceptibility: One Size Does not Fit All.

BRM Promoter Polymorphisms and Survival of Advanced Non-Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial.

Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk.

BRM polymorphisms, pancreatic cancer risk and survival

Frequent collaborators

Geoffrey Liu

Wei Xu

Stephen Lye

Kellie Murphy

Daphne Korczak

Mark Wade

Mark Wade

Patrick McGowan

Lesley Seymour

Flavia Marini

Glenwood Goss

Steven Gallinger

Osvaldo Espin Garcia

Michelle Cotterchio

Isabel Fortier

Laura Anderson

Jean-Patrice Baillargeon

Stephanie Atkinson

Catherine Birken

William Fraser